Connect with us

Featured

Stock Price Morning Market Newsletter – August 1, 2019

Daniel Chase

Published

on

stock price newsletter

Canadian Gold Stocks In Focus As Gold Price Reaches Multi-Year Breakout

This year has been a year of general uncertainty for investors due to a range of reasons. That has seen them parking their money in more stable assets. The trade war between the United States and China has resulted in a lot of uncertainty in markets. Furthermore, anxiousness regarding a rate cut from the US Federal Reserve has added more fuel to the fire.

Click Here To Read More


Oil Stock Prices Soar: Is Crude Oil Back In The Bull Trend

On Tuesday, the prices of some of the better known offshore oil drilling stocks soared and some of the stocks managed to gain as much as 10%. Why?…

Continue Reading


Is The Biotech Sector Ready For A Reversal?

With a wave of groundbreaking products in the pipeline, biotechnology could be poised to keep churning higher for the foreseeable future. But how can you get in on the ground floor of the next big wave in biotech?

See For Yourself

Continue Reading
Click to comment

Biotechnology

2 Biotech Stocks Witnessing Solid Momentum

Joe Samuel

Published

on

biotechnology stocks to buy now

Over the past half a decade or so, some sectors have emerged which have proven to be excellent grounds for good stock picks. The biotech sector is certainly among those sectors. Many of the companies in the biotech sector have come up with innovative solutions and rewarded investors who had backed them.

However, when it comes to discovering new winners from among biotech stocks, an investor needs to do his research and watch the latest evenings in the sector quite closely. On that note, here is a look at two biotech stocks that could be under consideration.

Adial Pharmaceuticals (ADIL)

top biotech stocks to watch list

The first biotech stock that could be added to the watch list is that of Adial Pharmaceuticals Inc (NASDAQ:ADIL), which recorded impressive gains on Friday after the company made a major announcement. Adial announced that the company has completed the validation of its genetic biomarker test that will be needed for the Phase 3 trial for its product AD04.

It’s a genetically targeted medicine that treats Alcohol Use Disorder. The news proved to be a major development for the company as it works towards creating this product and the market thought so as well. The stock rallied by as much 31% on Friday and will be among the biotech stocks to watch this week.

Matinas BioPharma Holdings (MTNB)

The other biotech that made significant gains in recent weeks is that of Matinas BioPharma Holdings Inc (NYSE:MTNB). The company announced on Thursday that it has entered into a feasibility evaluation with Roche Group member Genentech. This evaluation is related to the manufacturing of certain oral formulations by using oral formulations using Matinas’ lipid nano-crystal (LNC).

It is a major development for Matinas and one that could have far-reaching ramifications for the company. The stock soared by as much as 18% after the announcement was made. This is a biotech stock that could be tracked by investors this week.

Continue Reading

Biotechnology

Will Biotech Stocks Soar Into 2020?

Joe Samuel

Published

on

best biotech stocks to trade now

The stock market has been on a wild ride this year and December has shown no difference. When it comes down to it, making money in the stock market is simple. But it isn’t easy; let me explain.

For instance, if a sector is on the upward trajectory then it makes complete sense to have a look at some of the stocks in that arena. But then again, even if the sector is hot, it doesn’t mean every stock within it is.

Regardless, among the sectors that have shown impressive growth over the past few years biotech remains positive. and many investors have managed to make handsome returns. Here is a look at two biotech stocks that are worth considering at this point.

Tonix Pharmaceuticals Holding

The first biotech stock that could be out into the watch list is that of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) after the company made an important announcement. Tonix announced that it has been granted a patent by the European Patent Office for “Eutectic Formulations of Cyclobenzaprine Hydrochloride and Mannitol”.

The patent gives Tonix access to as many as 14 claims and also gives the company exclusive rights up until 2034. The development is a significant one and could have far-reaching implications for Tonix’s business in the years to come.The news was well-received by the markets as well and the stock rallied by as much as 23% on Thursday.

VBI Vaccines

The other stock that could be taken under consideration is the VBI Vaccines Inc (NASDAQ:VBIV). The company made a major announcement with regards to the Phase 1/2A study of its cancer vaccine immunotherapeutic In recurrent glioblastoma (GBM) patients medicine VB1-1901.

The company announced that it presented the data regarding the medicine at the 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. The event in question is an influential one and is a substantial achievement for VBI. The stock rallied by as much as 50%.

Continue Reading

Featured

Stock Price Newsletter – December 13, 2019

Joe Samuel

Published

on

stock market news

StockPrice Special Report: The $40 Billion Dollar Content Gold Rush

Click For Full Report


2 Biotech Stocks To Watch Before Next Week

See For Yourself


Streaming Wars and the Future of Companies Involved

Has The Time Come?

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com